Deputy First Minister announces Scottish Brain Sciences as anchor tenant in ONE BioHub Aberdeen

Our CEO, Prof Craig Ritchie, and Chair, Mark Cook, were delighted to meet with Deputy First Minister,Kate Forbes MSP, at our new base in ONE Biohub in Aberdeen. This is a great opportunity to discuss how we will improve equity of access to Alzheimer’s therapies in the north east, as well as wider life science advances across Scotland. Read more…

New Alzheimer’s Vaccine Trial in Scotland

Scottish Brain Sciences is delighted to be the first clinical site open in the UK & Europe, to deliver a clinical trial of a new active immunotherapy (a vaccine) aimed at preventing or slowing the progression of Alzheimer’s Disease.

Blood biomarkers can reveal Alzheimer disease progression, study finds

New blood tests for a protein linked with Alzheimer’s Disease can identify those patients whose disease is progressing. Read more about how these can be used to help design the next evolution in clinical trials…